BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18398099)

  • 1. Diseases desperate grown.
    Bunn PA
    J Natl Cancer Inst; 2008 Apr; 100(8):520-1. PubMed ID: 18398099
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
    Bregni M; Pedrazzoli P
    J Natl Cancer Inst; 2009 Jan; 101(1):67; author reply 67-8. PubMed ID: 19116385
    [No Abstract]   [Full Text] [Related]  

  • 3. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maintenance chemotherapy for small-cell lung cancer. A new publication].
    Margery J; Le Moulec S; Grassin F; Guigay J; Vaylet F; L'her P
    Rev Pneumol Clin; 2003 Jun; 59(3):179-80. PubMed ID: 13130207
    [No Abstract]   [Full Text] [Related]  

  • 5. Carboplatin for small cell lung cancer: progress toward greater efficacy and reduced toxicity.
    Raghavan D; Perez R; Creaven P; Takita H; Loewen G; Vaickus L
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):1-8. PubMed ID: 8052868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outpatient chemotherapy for small cell lung cancer in our hospital].
    Minami S; Asai M; Iwahori K; Kouga K; Nishiyama A; Komuta K
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1661-4. PubMed ID: 12355957
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
    Hosomi Y; Shibuya M
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1352-6. PubMed ID: 11681241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
    Perey L; Rosti G; Lange A; Pampallona S; Bosquée L; Pasini F; Humblet Y; Hamdan O; Cetto GL; Marangolo M; Leyvraz S
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S40-3. PubMed ID: 8899170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of small cell bronchogenic carcinoma in a patient on hemodialysis for chronic renal failure. Apropos of a case].
    Guillou B; Robinet G; Gouva S; Guillodo MP; Daniel C; Clavier J
    Rev Pneumol Clin; 1998 Sep; 54(4):215-8. PubMed ID: 9805752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Ifosphamide/CarboPlatin/Etoposide.
    Snee MP
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):165; author reply 165. PubMed ID: 12801057
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensified VICE regimen may improve SCLC survival.
    Oncology (Williston Park); 1996 Apr; 10(4):554. PubMed ID: 8723288
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.
    Fujimoto N; Ueoka H; Kiura K; Tabata M; Bessho A; Takata I; Sunami K; Hiramatsu Y; Ikeda K; Tanimoto M; Harada M
    Anticancer Res; 2003; 23(5b):4229-32. PubMed ID: 14666630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
    Musallam KM; Taher AT
    J Natl Cancer Inst; 2009 Dec; 101(23):1657; author reply 1657-8. PubMed ID: 19858426
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stage.
    Heigener DF; Manegold C; Jäger E; Saal JG; Zuna I; Gatzemeier U
    Am J Clin Oncol; 2009 Feb; 32(1):61-4. PubMed ID: 19194127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
    Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
    Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
    [No Abstract]   [Full Text] [Related]  

  • 16. [A patient with small cell lung cancer who developed a drug eruption due to concomitant therapy with carboplatin and etoposide].
    Yoshioka H; Kamohara R; Ikari H; Tamashima S; Kamimura H
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):487-90. PubMed ID: 18347401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemotherapy is essential for conservative surgery of Askin tumors.
    Veronesi G; Spaggiari L; De Pas T; Solli PG; De Braud F; Catalano GP; Curigliano G; Leo F; Pastorino U
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):428-9. PubMed ID: 12579122
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent developments in chemotherapy treatment of small-cell lung cancer.
    Johnson DH
    Semin Oncol; 1993 Aug; 20(4):315-25. PubMed ID: 8393591
    [No Abstract]   [Full Text] [Related]  

  • 19. An advance in small-cell lung cancer treatment--more or less.
    Laskin J; Sandler A; Johnson DH
    J Natl Cancer Inst; 2003 Aug; 95(15):1099-101. PubMed ID: 12902431
    [No Abstract]   [Full Text] [Related]  

  • 20. Etoposide effective against small cell lung cancer.
    Oncology (Williston Park); 1988 May; 2(5):12. PubMed ID: 2856322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.